Repligen Corporation develops and manufactures biochemical products for the healthcare market, primarily in the areas of AIDS, cancer and inflammation. The company's headquarters and its research and production facilities are in Cambridge, MA. Viral products that are in preclinical development include a pre-exposure protective HIV vaccine (with collaborator Merck & Co., Inc.), HIV...